ABSTRACT. Pulmonary surfactant proteins SP-B and SP-C were isolated from lavage fluids of bovine lungs and recombined (lipid/proteins, 911, wt/wt) with dipalmitoyl phosphatidylcholine for testing in vitro and in surfactantdeficient adult rats. Using a pulsating bubble surfactometer, we found that inflation pressures of bubbles at minimum radii in these mixtures were 0.34 f 0.05 cm H 2 0 (+ SD, n = 24) after 1 min. These values were not affected by increasing amounts of surfactant protein relative to dipalmitoyl phosphatidylcholine (DPPC). Minimum inflation pressures were similar to those of modified bovine surfactant, surfactant Tokyo Akita (TA) (0.33 f 0.05 cm H20, n = 7). I n vivo testing was carried out in adult rats made surfactant deficient by repeated lavage and ventilated with 100% oxygen. Rats received tracheal instillations of either air, DPPC, DPPCISP-B,C (9:1), or surfactant TA at 50 mg/kg body weight. Surfactant TA and DPPCISP-B, SP-C mixtures resulted in similar immediate and sustained improvements in arterial oxygenation (308 + 66 torr, n = 10 and 312 2 101 torr, n = 6 at 30 min posttreatment) that were significantly greater than those of sham (76 f 24 torr, n = 17) and DPPC-treated rats (64 f 32 torr, n = 7). Rats treated with either DPPC/SP-B,C mixtures or surfactant TA showed similar postmortem static lung compliances (2.3 f 0.8 ml/cm H20/kg, n = 8 and 1.9 2 0.4 ml/cm H20/kg, n = 5, respectively) that were significantly larger than sham (1.3 + 0.3 ml/cm H 2 0 / kg, n = 14) and DPPC-treated rats (1.2 f 0.2 ml/cm H20/ kg, n = 6). We conclude that simple mixtures of DPPC 
Many recent reports emphasized the functional importance, both in vitro and in vivo, of several pulmonary surfactant proteins with molecular weights that range between 5-26 kDa (1-1 1). These proteins are markedly hydrophobic (1, 5, (7) (8) (9) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) , coisolate with lipids in commonly used organic solvents (1, 4-8, 1 1, 13, [15] [16] [17] 20) and may represent monomeric and oligomeric forms of two distinct peptides-SP-B and SP-C (12, 16)-that are derived through proteolytic processing of larger precursor proteins (1, (21) (22) (23) (24) . Various reports indicate that SP-B and SP-C, together or separately, augment phospholipid recycling in cell cultures (13, 14, 19) , enhance absorption (1, 5-8, lo) , surface spreading and dynamic respreading (6, 7, 9, lo) , and surface tension-lowering properties of synthetic phospholipid mixtures or protein-free lipid extracts of natural surfactant in vitro (3-1 1) . SP-B and SP-C have also been reported to enhance the abilities of defined lipid mixtures to improve pulmonary compliance in the lungs of premature rabbits (2, 4, 6, 7, 9) . Many of these studies have only been published recently in preliminary form, and its remains unclear whether good separation techniques are readily available for separation of these two surfactant proteins, one from the other.
We have extended these studies by isolating SP-B,C from bovine lung lavage, combining these proteolipids with DPPC and testing the efficacy of these mixtures in vitro and in surfactant-deficient adult rats. Comparisons were made with DPPC alone and with a modified bovine surfactant used clinically for treatment of respiratory distress syndrome (surfactant TA, Tokyo Tanabe, Co., Tokyo).
MATERIALS AND METHODS
Isolation of proteins. SP-B,C were isolated from broncheoalveolar lavage of excised lungs from freshly sacrificed calves. Each lung was lavaged four to six times with approximately 0.3 liters of 0.15 M NaCl (4" C) that was poured intratracheally and removed by gravity flow with gentle massaging. Cells and debris were removed by centrifugation for 10 min at 500 or 1000 x g (4" C). The resulting supernatant was centrifuged at 20,000 x g for 1 h (4" C). The pelleted surfactant complex was extracted overnight three to four times with stirring in chloroform/methan01 (2: 1, vol/vol; 3 mg phospholipid/ml). Insoluble material was removed by centrifugation at 10,000 x g for 30 min (4" C).
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The supernatant from the final extraction was concentrated by partial evaporation of the solvent under nitrogen, then applied to either an analytic column (1 x 50 cm) or to a preparative column (2.5 x 100 cm) of Sephadex LH-20 that had been equilibrated in chloroform/methanol (2: 1, vol/vol). Loads of approximately 35 mgl0.5 ml or 400 mg/4 ml were applied to the columns, respectively. Elution with the same solvent was carried out at a flow rate of 0.34 ml/min (20" C). The effluent was monitored at 280 nm. Two-min fractions were collected and analyzed for protein by the methods of Lowry as modified by Peterson (26) or by amino acid analysis and by one-dimensional, SDS-PAGE (27) . The fractions containing protein from each chromatograph were collected and pooled with similar fractions from successive runs. The other lipid-rich fractions containing protein were also collected and rerun on the column.
Characterization of proteins. PAGE with SDS was camed out as previously described (15, 27, 28) using 15% acrylamide and 1.5 mm-thick slab gels with 3.5% acrylamide stacking gels. The gels were stained with silver stain kits from N.E. Nuclear (Boston, MA). Molecular weight markers included myoglobins: I11 (2. (29) as modified by Phelps et al. (28) using an immunoblotting apparatus (Bio-Rad, Richmond, CA) and nitrocellulose paper (Schleicher Schuell, Keene, NH) with a pore size of 0.05 pm. We used polyclonal rabbit antisera raised against surfactant TA proteins as previously described (34) to identify SP-B,C. We also used polyclonal rabbit antisera to the hydrophilic surfactant protein, SP-A, partially purified from pulmonary lavage of human patients with alveolar proteinosis (28, 30) .
Amino acid composition was determined from protein-rich LH-20 fractions that were hydrolyzed in 6 N HCl at 110" C for 24 h. Free amino acid composition was determined with a Beckman 6300 Amino Acid analyzer. The quantity of protein used in recombinant studies was determined either by amino acid analysis or by Lowry assay with values normalized to amino acid equivalents.
Lipid analysis. Measurements of phosphorus in crude surfactant, organic solvent soluble extracts, and Sephadex LH-20 eluates were camed out after Folch extraction (3 1) and quantified by the methods of Weinhold and Villee (32) . Samples of LH-20 eluates for lipid analysis were dried under nitrogen and redissolved in small volumes of chloroform/methanol(2: 1, vol/vol). The lipid components were separated by thin-layer chromatography on silica gel by using chloroform/methanol/2-propanoll water/triethylamine (30:9:25:7:25, by volume) (33) . After chromatography, solvents were removed by brief air drying followed by evaporation in an evacuated chamber for approximately 2 h. The plates were then sprayed with 70% sulfuric acid and charred overnight at 180" C.
Analysis of surface activity. The protein rich fractions in chloroform/methanol (2: 1, vol/vol) from column chromatography were mixed with synthetic DPPC (99 + % purity, Sigma) in chloroform/methanol (2: 1, vol/vol) to achieve ratios ranging between 100: 1 and 5: 1 (wt/wt) of DPPC to protein. All suspensions except surfactant TA were briefly vortexed, dried under nitrogen, dispersed in distilled water with brief vortexing, frozen (-70" C), lyophilized, and stored at -20" C until use. Surfactant TA was the generous gift of Tokyo Tanabe Co. Its composition has been described by us and others (34) (35) (36) . It was stored as a lyophilized powder at -70°C until use. All mixtures were dispersed in 0.15 M saline with sonication at 20% output (Branson Sonifier, model 185 with microtip) for three, 3-s bursts to a final concentration of 2.0 mg/ml. The dispersions were tested in a pulsating bubble surfactometer (37) . This instrument measures inflation pressures for a bubble in communication with ambient air in a surfactant suspension at 37" C. The bubble is made to pulsate at 20 cycles/min between minimum and maximum radii of 0.40 and 0.55 mm. We monitored inflation pressures for a 5-minute period after bubble creation.
In vivo testing. We adopted, with modification, the methods of Lachman et al. (38) and Taeusch et al. (34) for exogenous surfactant treatment of rats made surfactant deficient by multiple lavage. Adult, male Sprague-Dawley white rats weighing 0.355 + 0.062 kg were anesthetized with an intraperitoneal injection of pentobarbital (35 mg/kg) followed 20 min later by a subcutaneous injection of ketamine (80 mg/kg). A 14-gauge catheter was inserted into the trachea and tied (Fig. 1) . The left common carotid artery was then ligated, and a 22-gauge catheter was inserted proximal to the ligation into the artery for use in blood gas sampling, pressure monitoring, and fluid and drug administration. The animal was paralyzed with pancuronium bromide (0.1 mg/kg) given intraarterially. Anesthesia was maintained with hourly injection of ketamine (12 mg/kg) and injections of pancuronium (0.08 mg/kg) every 30 min and when paralysis declined. Body temperature was maintained using a heating pad (Delta Phase, Braintree Scientific, Braintree, MA) placed under the animal and with an overhead heat lamp. Physiologic saline with heparin (1000:l) was infused into the arterial catheter at 1.0 ml/h. Blood removed for analysis was returned and saline was injected periodically to replace blood volume that was lost.
Ventilation was maintained with oxygen (100%) at flow rates of 0.75 l/min (6.2 ml stroke volume) using a time-cycled ventilator (34) or by means of a volume-controlled ventilator (Harvard Apparatus Co., South Natick, MA, model 683) using stroke volumes of 7.2 ml/kg. Ventilator rates were adjusted to maintain the paCOz between 25 and 55 ton; our goal being 40-45 tom.
Arterial blood gases were obtained immediately before paral- ysis and artificial ventilation, 5 min after ventilation, and at 10-min intervals until blood gas concentrations were stable. Thirty min later the animals were given several sigh breaths (2 x V,) and lavaged four times by 20 ml/kg instillation and aspirations of saline (37" C). Additional lavages were performed if arterial paOz remained more than 120 torr after the first four lavages. Sigh breaths were given before each lavage and after the last lavage. After the last lavage, positive end expiratory pressure of 4 cm H,O was applied and maintained for the duration of the experiment. The animals received instillations of either air (sham treatment), DPPC, surfactant TA, or DPPC/protein (9: 1) after 30 min of stable blood gases.
The surfactants were prepared at a concentration of either 30 or 15 mg/ml 0.15 M saline and dispersed by brief sonication. Dilution to 15 mg/ml saline was done to reduce the viscosity of the DPPC and DPPC/protein mixtures (9, 39) . Surfactant TA, DPPC/protein, and DPPC-treated animals received dosages of 50 mg/kg. These instillations were carried out over a 5-min period in quarter doses with rats positioned supine, prone, and on either side to distribute the instillate. Sigh breaths were given after each quarter dose. Blood gases were obtained 5 min after surfactant administration and at 30-min intervals for up to 2 1/ 2 h.
At the termination of the experiment (approximately 2 h after instillation) the trachea was clamped and the lungs degassed (40) . Immediately after death, lung-thorax closed chest compliance was measured at one-half full inflation (8 ml) (41) and normalized to body weight.
Statistical analyses. Evaluation of statistical significance between groups was carried out by one-way analysis of variance with p < 0.0 1 accepted as significant.
RESULTS
Protein isolation. The chloroform/methanol soluble, bovine lung surfactant lipid extract contained approximately 1 % protein (by Lowry assay) relative to phospholipids by weight. Figure 2 illustrates the elution patterns of the proteins and phospholipids present in the lipid extracts after Sephadex LH-20 liquid chromatography. The proteins appeared slightly earlier than the main lipid peak that contained primarily phosphatidylcholine (frac- tions 1 1 -15), sphingomyelin (fractions 1 1 -15) , and phosphatidylethanolamine (fractions [15] [16] [17] [18] [19] (Fig. 3) . The more acidic phospholipids: phosphatidylserine (fraction number 30), phosphatidylinositol (fraction 57), and phosphatidylglycerol (fraction numbers 57 and 70) eluted later. In two pooled samples of protein-rich fractions, some lipid phosphorus was present giving an estimated phospholipid to protein weight (wt/wt) ratio of 2.4 (assuming phosphorus as 4% of phospholipid weight). Thin-layer chromatography of one of these samples showed that the principal lipid was phosphatidylcholine and there was some streaking of lipid through the remainder of the plate. Some charring occurred near the solvent front indicating the possibility that neutral lipids may have been present in the protein-rich fractions.
In the protein-rich fractions from Sephadex LH-20 chromatography, three major bands at 6, 14, and 18-26 kDa could be identified under nonreducing conditions by SDS-PAGE (Fig. 2) . When 2-mercaptoethanol was added to samples before electrophoresis, we observed almost no 18-to 26-kDa band and increased density in the 5-to 6-kDa and 14-kDa bands. When smaller amounts of protein were used for SDS-PAGE, bands only at 18-26 kDa could be seen under nonreducing conditions and at 5-6 kDa under reducing conditions. In other work, we o--o Phosphorous have determined that the unreduced band at 18-26 kDa contains SP-B and SP-C, and the unreduced bands at 5 and 14 kDa are SP-C (1 6). These proteins were immunoreactive with antibodies to surfactant TA. SP-A was not detected in liquid chromatography fractions by SDS-PAGE with silver staining or immunoblot analysis.
Pulsating bubble surfactometer. Suspensions of DPPC alone showed poor adsorption to the air-liquid interface (Fig. 4) and were ineffective at reducing the inflating pressures of the bubbles in the pulsating bubble surfactometer up to 5 min after bubble creation (Fig. 5, Table 1 ). The addition of 10% by weight of SP-B,C to DPPC resulted in increased adsorption rates (Fig. 4) and lower surface tension (Fig. 5 ) that were similar to those exhibited by surfactant TA (Fig. 4; Table 1 ). No additional reduction in surface tensions were seen when SP-B,C were increased to 20% by weight of DPPC. Based on these results, we used DPPC/SP-B,C (9: 1) for testing in surfactant-deficient adult rats.
In vivo comparisons. Sham-and DPPC-treated animals generally showed no improvement in arterial oxygenation after treatment (Fig. 6) . Animals receiving either surfactant TA or DPPC/SP-B,C (9: 1) mixtures showed improvements in arterial oxygenation at 5 min after treatment that were generally sustained for the experimental period. DPPC/SP-B,C and surfactant TA-treated rats generally maintained stable, normal blood paC02, and pH levels after treatment and had lungs that appeared well aerated on postmortem inspection. Static lung compliance measures for surfactant TA-(1.9 + 0.2 ml/cm H20/kg, n = 8) and DPPC/SP-B,C-treated rats (2.3 + 0.4 ml/cm HzO/kg, n = 5) were not significantly different from each other but were significantly greater than those of sham-(air) (1.3 + 0.1 ml/cm H20/kg) and DPPC-treated rats (1.2 + 0.1) ( p < 0.0 1). DISCUSSION We have tested the in vitro and in vivo efficacy of mixtures of DPPC and the small, hydrophobic proteins (SP-B,C) unique to pulmonary surfactant. Simple mixtures similar to those studied herein have been variously studied by a number of other investigators (Table 2 ) and have been shown to have many biophysical properties similar to natural surfactants. Because of different techniques for isolation and measurement of these proteins, the reported number and molecular weights of these proteins have varied. However, recently two small hydrophobic surfactant proteins with molecular weights of approximately 5 kDa under reducing conditions have been cloned (18, 21, 23) and their amino acid sequences reported (18, (20) (21) (22) (23) 25) . These two proteins have N-terminal amino acids of phenylalanine and leucine/ isoleucine when isolated from bovine lung, and evidence suggests that amino acid sequences are similar when these are proteins isolated from different species. Our test mixtures contained both SP-B (Phe) and SP-C (Leu/Ile) (1 6). We and others suspect that the native low molecular weight surfactant proteins are heterooligomers of these two gene products (12, 16) . For this reason (and because we were unable to isolate SP-B and SP-C separately in sufficient amounts for the in vivo studies), we used both SP-B and SP-C together in these studies of function. Our observation that the presence of SP-B,C enhances in vitro surface activity of DPPC is in qualitative agreement with others who have studied similar mixtures (5, 6, 9) . Our study is unique in that serial measures of gas exchange and measurement of static lung compliance were camed out in surfactant-deficient animals after treatment with DPPC/SP-B,C. Our study differs from some other studies in that we chose to use SP-B,C mixed with DPPC alone, without addition of other surfactant lipids. By so doing, it is possible that we needed a higher protein:DPPC ratio than others have found necessary when other protein and/or lipid surfactant constituents are included (2, 10) .
Whereas others (2, 4, 6, 7, 9) have tested mixtures similar to ours in premature rabbit fetuses, the rabbit model does not readily allow measurements of both gas exchange and lung mechanics over time. Nonetheless, the surfactant-deficient adult t In comparison to surfactant TA, p < 0.01.
-Shorn (17) -DPPC ( rat model has limitations as well, I ) an absence of lung immaturity, 2) possible damage to lung epithelium caused by the lavage procedure, and 3 ) potential effects of residual lavage fluid on the response by the lung to test mixtures. Using immature sheep (42,43) or primates (44) may be ideal models in which to test these mixtures, but limitations include the need for larger amounts of test material and expense. C/L *PIP, peak inspiratory pressure; PG, phosphatidyl glycerol; C/L, compliance of lung; P/S, pulsating surfactometer; K/C, King/Clements' measure of adsorption rate; W/B, Wilhelmy balance measure of surface tension; P/V, pressure/volume measures of lung; G/E, gas exchange; hist, histology; MW red, m.w. after reduction of sulfnydryl bonds. All in vivo studies with the exception of the current one were camed out in premature rabbits.
We have considered the possibility that our results with DPPC/ SP-B,C are due in part to the presence of lipid that coisolate with these proteins. It is not yet known whether part of the hydrophobicity of these proteins is due to covalent binding of lipid, i.e. whether these proteins are proteolipids. The only lipid that we could identify that coisolated with SP-B,C was phosphatidylcholine, and that was found in varying amounts in different batches. Based on these findings and the work of others, we think it unlikely that lipid bound to SP-B,C, rather than SP-B,C per se, is responsible for alteration of the biophysical behavior of the DPPC/SP-B,C dispersions.
In summary, our results clearly indicate that a simple aqueous dispersion of hydrophobic low molecular weight surfactant proteins and DPPC have in vitro and in vivo characteristics that are similar to a more extensively tested "natural" surfactant. Further testing of simpler surfactant mixtures may allow insights into mechanisms of action and metabolism of alveolar surfactant, and may offer new approaches for improved treatment of surfactant deficiency states.
